Voglibose/Metformin Hydrochloride

伏格列波糖/盐酸二甲双胍

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVoglibose/Metformin Hydrochloride
Drug Alias Name盐酸二甲双胍伏格列波糖Metformin Hydrochloride/Voglibose伏格列波糖盐酸二甲双胍Metformin/VogliboseVoglibose and Metformin +[10] 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylaseProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2011/01/01
Country/TerritoryIndia
CombinationsYes Metformin HydrochlorideVoglibose
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAthena Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAthena Pharma
Inactive CompaniesHK inno.N Corporation
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeA10BD
Related LinksN/A